Tag: Boston Scientific

Industry Focus Areas, Medical, News

Boston Scientific Q1 sales top expectations on ‘healthy’ market demand

April 26, 2023

Via: MedTech Dive

Boston Scientific reported first-quarter sales that exceeded the company’s forecast, saying it gained market share across its businesses as demand for procedures using its medical devices rebounded from a year ago. The company raised its full-year sales and profit forecasts, […]


Boston Scientific managed COVID-19, economic pressures in Q2, expects procedures to increase

July 27, 2022

Via: MedTech Dive

Boston Scientific weathered ongoing COVID-19 and macroeconomic pressures in the second quarter, leading the company to raise its 2022 forecast for organic revenue growth. CEO Michael Mahoney said on a Wednesday earnings call that the company now expects more “durable […]

Industry Focus Areas, Medical

Boston Scientific shares up on Q4, 2018 earnings Beat

February 6, 2019

Via: Mass Device

Shares in Boston Scientific (NYSE:BSX) have risen slightly this morning after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street. The Marlborough, Mass.-based company posted profits of $386 million, or 27¢ […]

Design & Planning, Industry Focus Areas, Medical, Process

Boston Scientific plans $200m restructuring

November 16, 2018

Via: Mass Device

Boston Scientific (NYSE:BSX) said yesterday that it’s planning a three-year restructuring program that’s slated to cost at least $200 million. The Marlborough, Mass.-based medical device maker said it expects to maintain roughly the same number of workers, although there will […]

Industry Focus Areas, Medical

Boston Scientific launches MRI-safe Resonate devices with HeartLogic diagnostic in U.S.

September 25, 2017

Via: Mass Device

Boston Scientific (NYSE:BSX) launched today its Resonate implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator systems with the HeartLogic heart failure diagnostic tool. The devices are approved by the FDA for conditional use in an MRI environment, the company reported. […]

Industry Focus Areas, Medical

Veniti inks distro deal with Boston Scientific for Vici venous stent

September 11, 2017

Via: Mass Device

Veniti said today it inked a limited global distribution deal with Boston Scientific (NYSE:BSX) for its Vici venous stent. The companies did not release details on which regions Boston Scientific would distribute the stent in or any financial terms of […]